Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...
RICHMOND, Va., January 14, 2026 – Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced a major advancement in AI-driven Active ...
Midland Reporter-Telegram on MSN
API chief: Venezuela tops energy watch list amid U.S. interest
API leaders say Venezuela and Iran developments could sway oil markets as U.S. output stays strong; they push permitting ...
Our Bureau, New Delhi Thursday, January 15, 2026, 16:30 Hrs [IST] ...
AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
A brand-new Linux malware named VoidLink targets victims' cloud infrastructure with more than 30 plugins that allow attackers ...
The fourth edition of Inc42’s AI Startups To Watch comprises names like Arrowhead, NYAI, Magicroll AI, Multibagg AI and 169Pi ...
Zero Tackle on MSN
Every NRL team’s premiership window
Premiership windows in the NRL are rarely static. They're shaped by a delicate balance of elite talent, roster age, ...
X’s Smart Cashtags embed real-time prices, charts, and asset data directly into timelines, reducing reliance on external ...
Jubilant Biosys Limited, a wholly owned subsidiary of Jubilant Pharmova Limited, and a global CRDMO operating from five sites across India and Europe, – announced the opening of a new discovery and ...
Explore the groundbreaking AI genomics platform, Inference, launched by Variant Bio to enhance drug discovery using genetic ...
Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback